SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21166702
Source:
http://linkedlifedata.com/resource/pubmed/id/21166702
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005684
,
umls-concept:C0035647
,
umls-concept:C0205314
,
umls-concept:C0297817
,
umls-concept:C0302350
,
umls-concept:C0679622
,
umls-concept:C1511876
,
umls-concept:C1521840
pubmed:issue
6
pubmed:dateCreated
2010-12-20
pubmed:abstractText
To examine the immunohistochemical expression and function of ribonucleotide reductase M2 subunit (RRM2), a gemcitabine-related molecule, in bladder cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7704136
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering
,
http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleoside Diphosphate Reductase
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
,
http://linkedlifedata.com/resource/pubmed/chemical/ribonucleotide reductase M2
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1365-2559
pubmed:author
pubmed-author:FukayamaMasashiM
,
pubmed-author:HommaYukioY
,
pubmed-author:KumeHarukiH
,
pubmed-author:MaedaDaichiD
,
pubmed-author:MorikawaTeppeiT
pubmed:copyrightInfo
© 2010 Blackwell Publishing Limited.
pubmed:issnType
Electronic
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
885-92
pubmed:meshHeading
pubmed-meshheading:21166702-Aged
,
pubmed-meshheading:21166702-Blotting, Western
,
pubmed-meshheading:21166702-Carcinoma, Squamous Cell
,
pubmed-meshheading:21166702-Cell Line, Tumor
,
pubmed-meshheading:21166702-Female
,
pubmed-meshheading:21166702-Humans
,
pubmed-meshheading:21166702-Immunohistochemistry
,
pubmed-meshheading:21166702-Lymphatic Metastasis
,
pubmed-meshheading:21166702-Male
,
pubmed-meshheading:21166702-Middle Aged
,
pubmed-meshheading:21166702-RNA, Small Interfering
,
pubmed-meshheading:21166702-Ribonucleoside Diphosphate Reductase
,
pubmed-meshheading:21166702-Tissue Array Analysis
,
pubmed-meshheading:21166702-Tumor Cells, Cultured
,
pubmed-meshheading:21166702-Tumor Markers, Biological
,
pubmed-meshheading:21166702-Urinary Bladder Neoplasms
,
pubmed-meshheading:21166702-Urothelium
pubmed:year
2010
pubmed:articleTitle
Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer.
pubmed:affiliation
Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. tmorikawa-tky@umin.ac.jp
pubmed:publicationType
Journal Article